RecruitingNot Applicable

Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations

France2,920 participantsStarted 2025-11-19

Plain-language summary

The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. For the assessment of pneumococcal coverage among patients eligible for this vaccination:
✓. For the assessment of pertussis vaccination among pregnant women:

What they're measuring

Number of subjects vaccinated against pneumococcal infections

Timeframe: Month 3

Number of subjects vaccinated against pneumococcal infections

Timeframe: Month 18

Number of subjects vaccinated against pertussis

Timeframe: Month 3

Number of subjects vaccinated against pertussis

Timeframe: Month 18

Trial details

NCT IDNCT07243236

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-05

Contact for this trial

Marie LACHATRE, MD

0033158412093 marie.lachatre@aphp.fr

View on ClinicalTrials.gov More Healthcare Providers trials